Life-Sciences-Asia.com
The Asian Life Sciences Web Portal

This is a free web portal for the life sciences in Asia... » read more

Azenta to Acquire B Medical Systems for up to €460m (2022-08-08)
Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"), ...
F2G Ltd: $70m Financing Led by Forbion & Sofinnova Partners (2022-08-04)
New Investment from Forbion and Sofinnova Partners F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical need, today announces ...
Sosei Heptares & AbbVie: New Collaboration with $80m Upfront (2022-08-02)
> New strategic collaboration leverages Sosei Heptares’ StaR® technology and SBDD platform and AbbVie’s extensive neuroscience expertise > Second collaboration with AbbVie follows 2020 agreement focused on inflammatory and autoimmune diseases > Sosei Heptar...
Eppendorf Opens New Site in Singapore (2022-08-01)
> New subsidiary at the center of the Asian life science growth markets > Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services > Even faster and more reliable delive...
Manifold Bio Raises $40m Series A Led by Triatomic Capital (2022-07-14)
Triatomic Capital’s Jeff Huber to Join Board of Directors with this Funding Manifold Bio, a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a $40 million Series A financing round led by...
Heidelberg Pharma & Chiome Bioscience: ADC Agreement (2022-07-13)
Ad hoc announcement Inside information pursuant to Article 17 MAR Heidelberg Pharma AG (FSE: HPHA) and Chiome Bioscience Inc., Tokyo, Japan, (Tokyo: 4583) today announced the signing of an exclusive, target-specific research and option agreement. Heidelberg P...
BeiGene Appoints Chan Lee as General Counsel (2022-07-13)
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology biotechnology company focused on developing and commercializing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced the appointment ...
Epic Bio Emerges with $55m Series A & CEO Amber Salzman (2022-07-12)
– $55 million Series A financing will advance the company’s robust preclinical pipeline and ongoing discovery efforts – – Epic holds exclusive license to smallest known Cas protein, enabling in vivo delivery via AAV vector to wide range of target organs – – ...
Phytolon Closes $14.5m Series A Led by DSM Venturing (2022-07-07)
Phytolon, a developer of fermentation-based natural food colors, announced today it has secured $14.5 million in funding, led by DSM Venturing, to further progress its technology towards commercialization, with participation from Cibus Fund, Ginkgo Bioworks (in-kin...
BeiGene & InnoRNA to Jointly Discover Novel mRNA Therapies (2022-07-06)
> BeiGene and InnoRNA will jointly research a number of mRNA-LNP programs, and BeiGene will hold exclusive global development and commercialization rights for the product candidates from the programs > BeiGene will also gain a non-exclusive license to InnoRNA’s ...

Life-Sciences-Asia.com is your doorway to the Asian life sciences!

[LSA] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Asian region.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]